Search

everythinglearnresearchcommunity

for

Search:↓

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

Suppressing ODC activity reduces tumor growth in hair follicles.

N-acetylcysteine may help treat trichotillomania.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

5α-Reductase inhibitors don't cause depression.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Combining methotrexate and corticosteroids can effectively regrow hair in severe alopecia areata.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

5α-reductase 2 is crucial for stress response in male rats.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

The treatment with valproate, acetylcarnitine, folic acid, and vitamin B12 may improve muscle strength in children with SMA without significant side effects.

Methotrexate is not proven to maintain remission in ulcerative colitis.

Certain drugs that block specific enzymes can help treat prostate diseases.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

Finasteride and dutasteride may cause depression and anxiety, especially in younger men.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

Herbal drugs show promise for treating alopecia with fewer side effects, but standardization is challenging.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.